...
首页> 外文期刊>International journal of infectious diseases: IJID : official publication of the International Society for Infectious Diseases >Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
【24h】

Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.

机译:埃及小儿癌症患者严重血液感染的临床和微生物学决定因素:为期一年的研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Bloodstream infections (BSI) remain a major cause of morbidity and death in patients undergoing treatment for cancer. However, all recent epidemiological and therapeutic studies underline the absolute need for knowledge of the factors governing the infections in each center. The aim of this study is to identify the factors affecting BSI in the pediatric service of the National Cancer Institute (NCI) at Cairo University. More tailored policies for the treatment of patients with febrile neutropenia following chemotherapy can then be created. PATIENTS AND METHODS: Over a 12-month period, all children with cancer and fever, with or without neutropenia, who were admitted to the NCI for empirical therapy of febrile episodes and who had a microbiologically confirmed bloodstream infection were studied retrospectively. RESULTS: A total of 328 BSI occurred in 1135 febrile episodes in pediatric cancer patients at the NCI in one year. Gram-positive bacteria were isolated in 168 episodes (51.2%) and 61.9% of the total isolates (either single or mixed), Gram-negative in 97 (29.6%), and mixed infections in 45 (13.7%). The common causative agents of bloodstream infections in this study were coagulase-negative staphylococci (16.2%), Staphylococcus aureus (13.4%), Streptococcus spp. (12.1%) followed by Acinetobacter spp. (6.7%) and Pseudomonas spp. (5.5%). Fungemia was encountered in 18 episodes, being mixed in nine of them. A more serious BSI in terms of a prolonged episode was encountered in 30.2% of the episodes and was significantly associated with patients being hospitalized, having intensified chemotherapy, polymicrobial and fungal infection, lower respiratory tract infections and persistent neutropenia at day seven. CONCLUSIONS: In a large population of children, common clinical and laboratory risk factors were identified that can help predict more serious BSI. These results encourage the possibility of a more selective management strategy for these children.
机译:目的:血流感染(BSI)仍然是接受癌症治疗的患者发病和死亡的主要原因。然而,所有最近的流行病学和治疗学研究都强调了绝对需要掌握每个中心感染因素的知识。这项研究的目的是确定影响开罗大学国家癌症研究所(NCI)儿科服务的BSI的因素。然后可以创建针对化疗后高热性中性粒细胞减少症患者的更适合的治疗策略。患者和方法:在过去的12个月中,回顾性研究了所有接受过NCI入院治疗高热发作并经微生物学证实为血液感染的癌症和发烧儿童,无论是否患有中性粒细胞减少。结果:一年中,在NCI的小儿癌症患者中,在1135例高热发作中发生了328例BSI。革兰氏阳性菌的分离率为168例(51.2%),占总分离株的61.9%(单株或混合菌),革兰氏阴性菌为97例(29.6%),混合感染的为45例(13.7%)。本研究中常见的引起血液感染的病原是凝固酶阴性葡萄球菌(16.2%),金黄色葡萄球菌(13.4%),链球菌。 (12.1%),其次是不动杆菌属。 (6.7%)和假单胞菌属。 (5.5%)。在18集中遇到了真菌病,其中有9集混杂在一起。就发作延长而言,在30.2%的发作中出现了更为严重的BSI,并且与住院的患者显着相关,在第七天,患者接受了加强的化学疗法,微生物和真菌感染,下呼吸道感染和持续中性粒细胞减少。结论:在大量儿童中,确定了常见的临床和实验室危险因素可以帮助预测更严重的BSI。这些结果鼓励了对这些儿童采取更具选择性的管理策略的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号